EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Generating and Expanding Conventional Type 1 Dendritic Cells

Sukriti Sharma, Shandré Pillay, Christian T Mayer

European Journal of Immunology · 2026-10 · 56 (10)

DOI: 10.1002/eji.70307 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 28.10.2026. Verfasst von Sukriti Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Dendritic Cells. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health (NIH), U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional type 1 dendritic cells (cDC1s) are specialized antigen‐presenting cells that play essential roles in cross‐presentation, immunity to intracellular pathogens, and antitumor immune responses. Their low abundance and limited accessibility in blood and many tissues have driven extensive efforts to generate and expand cDC1s for mechanistic and translational studies. Over the past two decades, advances in cDC1 biology have transformed the field from heterogeneous bone marrow‐derived cultures to increasingly sophisticated platforms that generate, enrich, or expand bona fide cDC1s, alongside approaches whose products remain best described as cDC1‐like. Here, we review cytokine‐driven cultures, Notch ligand‐supported systems, human CD34 + progenitor and induced pluripotent stem cell‐derived platforms, transcription factor‐based programming, and endogenous cDC1 expansion. We distinguish bona fide cDC1s, cDC1‐enriched cultures, and cDC1‐like cells and compare these approaches by lineage validation, enrichment, yield, culture duration, function, scalability, and translational maturity. Together, these platforms provide complementary tools for cDC1 research and therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsHumansAnimalsCell DifferentiationHematopoietic Stem Cells

Stichwörter der Autor:innen

cDC1cellular engineeringdendritic cell differentiationhematopoietic progenitorsimmunotherapy

Autor:innen und Institutionen

  • Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Förderung

  • National Institutes of Health (NIH)
  • U.S. Department of Health and Human Services

Zitieren

APA

Sharma, S., Pillay, S., & Mayer, C. T. (2026). Generating and Expanding Conventional Type 1 Dendritic Cells. European Journal of Immunology, 56(10). https://doi.org/10.1002/eji.70307

Vancouver

Sharma S, Pillay S, Mayer CT. Generating and Expanding Conventional Type 1 Dendritic Cells. European Journal of Immunology. 2026;56(10). doi:10.1002/eji.70307

BibTeX
@article{Sharma2026,
  author = {Sharma, Sukriti and Pillay, Shandré and Mayer, Christian T},
  title = {Generating and Expanding Conventional Type 1 Dendritic Cells},
  journal = {European Journal of Immunology},
  year = {2026},
  volume = {56},
  number = {10},
  doi = {10.1002/eji.70307}
}
Kostenlos starten →